home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

A Promising Target For Heart Failure Treatment

  February, 17 2004 10:15
your information resource in human molecular genetics
In the March issue of Nature Medicine, Jeffrey Molkentin and colleagues report a new strategy to treat heart disease by inhibiting the enzyme protein kinase C-alpha (PKC-alpha).

PKC-alpha is expressed at higher levels in heart failure patients, but the significance of this increase had not been well understood. Molkentin and colleagues used three mouse models of heart disease to show that deleting the gene that encodes PKC-alpha from the diseased heart improves its function. In two of the models, the technique helped the mice survive longer. The authors also show that PKC-alpha directly controls the activity of key enzymes that regulate heart muscle contraction.

The authors' findings help explain the mechanisms behind heart muscle contraction, and suggest that PKC-alpha could be a pharmacologic target for treating human heart failure.

Author contact:

Jeffrey D. Molkentin
Children's Hospital Medical Center
Cincinnati, OH
Tel: +1 513 636 3557
E-mail: jeff.molkentin@cchmc.org

Abstract available online.

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.